case_images: PMC10868506_01
case_images: (a)-(c) Baseline (November 2022), (d) 4 months of protopic (March 2023) (e)-(g) (November 2023) after stopping abrocitinib for 4 months.
case_images: 10.1177_2050313X241231527-fig1.jpg
case_images: PMC10868506_01_10.1177_2050313X241231527-fig1.jpg
case_images: fig1-2050313X241231527
case_images: He was referred to dermatology in November 2022, (Figure 1(a)) and was prescribed tacrolimus 0.1% ointment to be applied twice a day (BID). After 2 months on abrocitinib, patient was switched back to tacrolimus 0.1% daily for maintenance with no relapse and further repigmentation at 4 months off abrocitinib Figure 1(e)-(g).